Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Hemoglobin

Retrieve available abstracts of 72 articles:
HTML format

Single Articles

    November 2021
  1. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    PubMed     Abstract available

    June 2021
  2. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    PubMed     Abstract available

    May 2021
  3. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    PubMed     Abstract available

    March 2021
  4. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    PubMed     Abstract available

    January 2021
  5. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    PubMed     Abstract available

  6. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    PubMed     Abstract available

    November 2020
  7. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    PubMed     Abstract available

    July 2020
  8. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    PubMed     Abstract available

    May 2020
  9. PINTO VM, Derchi GE, Bacigalupo L, Pontali E, et al
    COVID-19 in a Patient with beta-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
    Hemoglobin. 2020;44:218-220.
    PubMed     Abstract available

    March 2020
  10. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    PubMed     Abstract available

  11. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    PubMed     Abstract available

  12. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    PubMed     Abstract available

  13. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    PubMed     Abstract available

  14. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    PubMed     Abstract available

  15. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    PubMed     Abstract available

  16. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    PubMed     Abstract available

  17. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    PubMed     Abstract available

  18. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    PubMed     Abstract available

  19. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    PubMed     Abstract available

  20. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    PubMed     Abstract available

  21. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    PubMed     Abstract available

  22. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    PubMed     Abstract available

    January 2020
  23. SEMKIU KM, Oliveira JL, Nguyen PL, Porter TR, et al
    Hb F-Wentzville [(G)gamma24(B6)Gly-->Glu; HBG2: c.74G>A, p.Gly25Glu]: An Unstable (G)gamma-Globin Variant Associated with Neonatal Hemolytic Anemia.
    Hemoglobin. 2020 Jan 27:1-3. doi: 10.1080/03630269.2020.1716002.
    PubMed     Abstract available

  24. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    PubMed     Abstract available

  25. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    PubMed     Abstract available

  26. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    PubMed     Abstract available

  27. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    PubMed     Abstract available

  28. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    PubMed     Abstract available

  29. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    PubMed     Abstract available

  30. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    PubMed     Abstract available

  31. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    PubMed     Abstract available

  32. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    PubMed     Abstract available

  33. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    PubMed     Abstract available

  34. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    PubMed     Abstract available

  35. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    PubMed     Abstract available

  36. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    PubMed     Abstract available

    December 2019
  37. MAKIS A, Georgiou I, Traeger-Synodinos J, Storino MR, et al
    A Novel epsilongammadeltabeta-Thalassemia Deletion Associated with Severe Anemia at Birth and a beta-Thalassemia Intermedia Phenotype Later in Life in Three Generations of a Greek Family.
    Hemoglobin. 2019 Dec 12:1-4. doi: 10.1080/03630269.2019.1699568.
    PubMed     Abstract available

    October 2019
  38. JIANG H, Jiang F, Li J, Tang F, et al
    Congenital Nonspherocytic Hemolytic Anemia Caused by Kruppel-Like Factor 1 Gene Variants: Another Case Report.
    Hemoglobin. 2019 Oct 23:1-4. doi: 10.1080/03630269.2019.1680384.
    PubMed     Abstract available

    May 2019
  39. ADEYEMO TA, Diaku-Akinwunmi IN, Ojewunmi OO, Bolarinwa AB, et al
    Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
    Hemoglobin. 2019;43:188-192.
    PubMed     Abstract available

  40. CANNATA M, Cassara F, Vinciguerra M, Licari P, et al
    Double Heterozygosity for Hb Durham-N.C. (HBB: c.344T>C) [beta114(G16)Leu-->Pro] and the IVS-I-110 (HBB: c.93-21G>A) Causing a Severe beta-Thalassemia Phenotype.
    Hemoglobin. 2019;43:210-213.
    PubMed     Abstract available

  41. SAFAEI S, Abedi H, Parand S, Karimi M, et al
    Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in beta-Thalassemia Major Patients in Southern Iran.
    Hemoglobin. 2019;43:198-203.
    PubMed     Abstract available

  42. WANG MK, Shergill R, Jefkins M, Cheung J, et al
    A sickle cell disease patient with dural venous sinus thrombosis: a case report and literature review.
    Hemoglobin. 2019;43:193-197.
    PubMed     Abstract available

  43. YILMAZ S
    The Spectrum of beta-Thalassemia Mutations in Siirt Province, Southeastern Turkey.
    Hemoglobin. 2019;43:174-181.
    PubMed     Abstract available

  44. BORGES E, Tchonhi C, Couto CSB, Gomes V, et al
    Unusual beta-Globin Haplotype Distribution in Newborns from Bengo, Angola.
    Hemoglobin. 2019;43:149-154.
    PubMed     Abstract available

  45. YASSOUF MY, Alquobaili F, Kabalan Y, Mukhalalaty Y, et al
    Compliance with Deferoxamine Therapy and Thyroid Dysfunction of Patients with beta-Thalassemia Major in Syria.
    Hemoglobin. 2019;43:218-221.
    PubMed     Abstract available

  46. HASAN KN, Sufian A, Mazumder AK, Khaleque MA, et al
    A Novel Pathogenic beta-Thalassemia Mutation Identified at Codon 8 (HBB: c.27delG) in a Bangladeshi Family Acquired De Novo.
    Hemoglobin. 2019;43:162-165.
    PubMed     Abstract available

  47. ABDULLAH UYH, Ibrahim HM, Mahmud NB, Salleh MZ, et al
    Quadrupole-Time-of-Flight Mass Spectrometric Identification of Hemoglobin Subunits alpha, beta, gamma and delta in Unknown Peaks of High Performance Liquid Chromatography of Hemoglobin in beta-Thalassemias.
    Hemoglobin. 2019;43:182-187.
    PubMed     Abstract available

  48. HADIPOUR DEHSHAL M, Tabrizi Namini M, Hantoushzadeh R, Yousefi Darestani S, et al
    beta-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
    Hemoglobin. 2019;43:166-173.
    PubMed     Abstract available

    March 2019
  49. MORADI K, Aznab M, Tahmasebi S, Dastafkan Z, et al
    The Spectrum of alpha-Thalassemia Mutations in the Lak Population of Iran.
    Hemoglobin. 2019;43:107-111.
    PubMed     Abstract available

  50. JIT BP, Mohanty PK, Pradhan A, Purohit P, et al
    Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India.
    Hemoglobin. 2019;43:88-94.
    PubMed     Abstract available

  51. ZHOU JY, Jiang F, Li J, Chen GL, et al
    Coinheritance of Hb City of Hope (HBB: c.208G>A) and beta-Thalassemia: Compromising the Molecular Diagnosis of the Codons 71/72 (+A) (HBB: c.216_217insA) Mutation by Reverse Dot-Blot Hybridization.
    Hemoglobin. 2019;43:145-147.
    PubMed     Abstract available

  52. HEIREMAN L, Luyckx A, Schynkel K, Dheedene A, et al
    Detection of a Large Novel alpha-Thalassemia Deletion in an Autochthonous Belgian Family.
    Hemoglobin. 2019;43:112-115.
    PubMed     Abstract available

  53. YANG K, Ren Q, Wu Y, Zhou Y, et al
    A Case of Hereditary Spherocytosis Caused by a Novel Homozygous Mutation in the SPTB Gene Misdiagnosed as beta-Thalassemia Intermedia Due to a KLF1 Gene Mutation.
    Hemoglobin. 2019;43:140-144.
    PubMed     Abstract available

  54. NGIM CF, Lee MY, Othman N, Lim SM, et al
    Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Hemoglobin. 2019;43:95-100.
    PubMed     Abstract available

  55. ADEKILE AD, Al-Sherida S, Marouf R, Mustafa N, et al
    The Sub-Phenotypes of Sickle Cell Disease in Kuwait.
    Hemoglobin. 2019;43:83-87.
    PubMed     Abstract available

  56. SUN M, Lou J, Zhag Y, Fu Y, et al
    Polymorphisms of alpha-Globin Genes Compromise Polymerase Chain Reaction-Based alpha-Thalassemia Genotyping in Three Chinese Families.
    Hemoglobin. 2019;43:101-106.
    PubMed     Abstract available

  57. XIE XM, Liu YN, Li J, Jiang F, et al
    A Kruppel-Like Factor 1 Gene Mutation Ameliorates the Severity of beta-Thalassemia: A Case Report.
    Hemoglobin. 2019;43:137-139.
    PubMed     Abstract available

    January 2019
  58. AZIMI A, Nejati P, Tahmasebi S, Alimoradi S, et al
    Characterization of the IVS-II-821 (A>C) (HBB: c.316-30A>C) Mutation in a beta-Thalassemia Phenotype in Iran.
    Hemoglobin. 2019;43:23-26.
    PubMed     Abstract available

  59. NUINOON M, Thipthara O, Fucharoen S
    Compound Heterozygote for a Novel Elongated C-Terminal beta-Globin Variant (HBB: c.364delG) and Hb E (HBB: c.79G>A) with Heterozygous alpha-Thalassemia-2.
    Hemoglobin. 2019;43:52-55.
    PubMed     Abstract available

  60. JIANG F, Li J, Zhou JY, Liao C, et al
    Regulatory Single Nucleotide Polymorphism rs368698783 (G>A): a Genetic Modifier of Hb F Production Only under Erythropoietic Stress Characteristic for beta-Globin Chain Deficiency?
    Hemoglobin. 2019;43:73-75.
    PubMed     Abstract available

  61. ALIBAKHSHI R, Moradi K, Aznab M, Azimi A, et al
    The Spectrum of beta-Thalassemia Mutations in Hamadan Province, West Iran.
    Hemoglobin. 2019;43:18-22.
    PubMed     Abstract available

  62. CURCIO C, Giannone V, Benzoni E, Cesaretti C, et al
    Hb Milano [alpha109(G16)Leu-->Pro (CTG>CCG); HBA1: c.329T>C]: A Novel Variant on the alpha1-Globin Gene in an Italian Family.
    Hemoglobin. 2019;43:4-6.
    PubMed     Abstract available

  63. SU Q, Chen S, Wu L, Tian R, et al
    Severe Thalassemia Caused by Hb Zunyi [beta147(HC3)Stop-->Gln; HBB: c.442T>C)] on the beta-Globin Gene.
    Hemoglobin. 2019;43:7-11.
    PubMed     Abstract available

  64. PARSAEE M, Pouraliakbar H, Azarkeivan A, Ghadrdoost B, et al
    The Role of Exercise Stress Echocardiography for Determination of Subclinical Cardiac Involvement in beta-Thalassemia Major.
    Hemoglobin. 2019;43:34-37.
    PubMed     Abstract available

  65. AGBUDUWE C, Rugless M, Asba N, Proven M, et al
    Severe Drug-Induced Hemolysis in a Patient with Compound Heterozygosity for Hb Peterborough (HBB: c.334G>T) and Hb Lepore-Boston-Washington (NG_000007.3: g.63632_71046del).
    Hemoglobin. 2019;43:56-59.
    PubMed     Abstract available

  66. KOLLIOPOULOU A, Siamoglou S, John A, Sgourou A, et al
    Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in beta-Thalassemia Intermedia: A Validation Cohort Study.
    Hemoglobin. 2019;43:27-33.
    PubMed     Abstract available

  67. INTASAI N, Phasit A, Panyasai S, Pornprasert S, et al
    A Case Report of Compound Heterozygosity for beta(0)/beta(+)-Thalassemia Resulting from under Diagnosed beta-Thalassemia Found in a Hb A'2 Sample.
    Hemoglobin. 2019;43:63-65.
    PubMed     Abstract available

  68. YAO X, Xu LH, Xu HG, Li XY, et al
    Iron Metabolism and Oxidative Status in Patients with Hb H Disease.
    Hemoglobin. 2019;43:38-41.
    PubMed     Abstract available

  69. BHAT A, Neculiseanu E, Tam EL, Gendy A, et al
    Purulent Pericarditis in Sickle Cell Disease Due to Streptococcus agalactiae; a Unique Case Report and Literature Review.
    Hemoglobin. 2019;43:1-3.
    PubMed     Abstract available

  70. MURAD H, Moassas F
    First Report on the Coinheritance of alpha-Thalassemia and a Rare beta-Thalassemia Compound Heterozygosity for the IVS-I-I(G>A)/IVS-II-705(T>G) Mutations in a Syrian Family.
    Hemoglobin. 2019;43:66-68.
    PubMed     Abstract available

  71. ZHAO Y, Lou J, Sun M, Fu Y, et al
    Hb H Disease Results from Compound Heterozygosity of - -(SEA) and -alpha(MAL3.5) in a Chinese Family.
    Hemoglobin. 2019;43:69-72.
    PubMed     Abstract available

  72. TAMADDONI A, Khabaz Astaneh S, Tabaripour R, Akhavan-Niaki H, et al
    Kruppel-Like Factor 1 Gene Mutations in Thalassemia Patients from North Iran: Report of a New Mutation Associated with beta-Thalassemia Intermedia.
    Hemoglobin. 2019;43:12-17.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.